Osteocalcin Levels in Male Idiopathic Hypogonadotropic Hypogonadism: Relationship With the Testosterone Secretion and Metabolic Profiles
- PMID: 31681165
- PMCID: PMC6798147
- DOI: 10.3389/fendo.2019.00687
Osteocalcin Levels in Male Idiopathic Hypogonadotropic Hypogonadism: Relationship With the Testosterone Secretion and Metabolic Profiles
Abstract
Idiopathic hypogonadotropic hypogonadism (IHH) patients are characterized by the absence of puberty and varying degrees of deteriorated metabolic conditions. Osteocalcin (OC) could regulate testosterone secretion and energy metabolism, but it remains unknown whether such an effect exists in IHH patients. Our study is aimed to examine the relationship between serum OC levels with testosterone and its responsiveness to gonadotropin stimulation and metabolic profiles in male IHH patients. A total of 99 male patients aged 18-37 years and diagnosed with IHH were enrolled in the current study, and the relationships between OC and testicular volume, baseline total testosterone (TT), free testosterone (FT), and peak TT (Tmax) levels after human chorionic gonadotropin (hCG) stimulation, gonadotropin responsiveness index (GRI), which is calculated by dividing Tmax by testicular volume, as well as metabolic profiles, such as 2-h post-challenge glucose (2hPG) and fat percentage (fat%), were analyzed. The results showed that OC had an independent negative relationship with testicular volume (r = -0.253, P = 0.012) and a positive association with Tmax (r = 0.262, P = 0.014) after adjusting for confounders. In addition, OC was a major determinant of GRI (adjusted R 2 for the model = 0.164, P = 0.012), fat% (adjusted R 2 for the model = 0.100, P = 0.004), and 2hPG (adjusted R 2 for the model = 0.054, P = 0.013) in IHH patients. In conclusion, OC is associated with testosterone secretion upon gonadotropin stimulation, glucose metabolism, and fat mass variations in IHH. This study was registered at clinicaltrials.gov (NCT02310074).
Keywords: gonadotropin; idiopathic hypogonadotropic hypogonadism; metabolism; osteocalcin; testosterone.
Copyright © 2019 Yang, Zheng, Wang, Yang, Shan, Zhang, Qi, Chen, Gu, Wang, Zhao, Liu and Sun.
Figures
Similar articles
-
[Testicular findings, endocrine features and therapeutic responses of men with idiopathic hypogonadotropic hypogonadism].Nihon Naibunpi Gakkai Zasshi. 1995 May 20;71(4):605-22. doi: 10.1507/endocrine1927.71.4_605. Nihon Naibunpi Gakkai Zasshi. 1995. PMID: 7796925 Clinical Trial. Japanese.
-
Prediction of testosterone response to human chorionic gonadotrophin in idiopathic hypogonadotropic hypogonadism patients.J Natl Med Assoc. 2009 Jan;101(1):71-6. doi: 10.1016/s0027-9684(15)30814-2. J Natl Med Assoc. 2009. PMID: 19245075 Clinical Trial.
-
Effects of gonadotropin and testosterone treatments on prostate volume and serum prostate specific antigen levels in male hypogonadism.Endocr J. 1997 Oct;44(5):719-24. doi: 10.1507/endocrj.44.719. Endocr J. 1997. PMID: 9466329
-
Metabolic Disorders and Male Hypogonadotropic Hypogonadism.Front Endocrinol (Lausanne). 2019 Jul 25;10:345. doi: 10.3389/fendo.2019.00345. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31402895 Free PMC article. Review.
-
Long-term outcome of idiopathic hypogonadotropic hypogonadism.Curr Opin Endocrinol Diabetes Obes. 2012 Jun;19(3):204-10. doi: 10.1097/MED.0b013e328353565b. Curr Opin Endocrinol Diabetes Obes. 2012. PMID: 22499222 Review.
Cited by
-
In vitro effects of uncarboxylated osteocalcin on buffalo Leydig cell steroidogenesis.Vet Res Commun. 2024 Jun;48(3):1423-1433. doi: 10.1007/s11259-024-10320-4. Epub 2024 Feb 2. Vet Res Commun. 2024. PMID: 38305958
-
Total osteocalcin levels are independently associated with worse testicular function and a higher degree of hypothalamic-pituitary-gonadal axis activation in Klinefelter syndrome.J Endocrinol Invest. 2024 Dec;47(12):3049-3056. doi: 10.1007/s40618-024-02390-7. Epub 2024 May 21. J Endocrinol Invest. 2024. PMID: 38773059 Free PMC article.
-
Lipocalin 2-A bone-derived anorexigenic and β-cell promoting signal: From mice to humans.J Diabetes. 2024 Mar;16(3):e13504. doi: 10.1111/1753-0407.13504. Epub 2023 Nov 30. J Diabetes. 2024. PMID: 38035773 Free PMC article. Review.
References
-
- Segal TY, Mehta A, Anazodo A, Hindmarsh PC, Dattani MT. Role of gonadotropin-releasing hormone and human chorionic gonadotropin stimulation tests in differentiating patients with hypogonadotropic hypogonadism from those with constitutional delay of growth and puberty. J Clin Endocrinol Metab. (2009) 94:780–5. 10.1210/jc.2008-0302 - DOI - PubMed
Associated data
LinkOut - more resources
Full Text Sources